Skip to main content

Cancer Center

The Cancer Center at Illinois brings together cancer biologists, clinicians, engineers, and other specialists to accelerate advances in disease detection, prevention, therapy, and improve quality of life for patients.


Unprecedented Compound Takes a Step Toward Breast Cancer Clinical Trials

Estrogen receptor-positive breast cancer is the most common form of breast cancer, affecting approximately 75 percent of breast cancer patients. In advanced and metastatic form, it is lethal, claiming the lives of nearly 350,000 individuals annually. Presently, no drug is able to eradicate these...

Team identifies key driver of cancer cell death pathway that activates immune cells

Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.

Researchers identify new patterns of cell interactions with molecular chaperone

Through a new approach of cross-linking cell proteins directly to a protein of interest, researchers at the University of Illinois Urbana-Champaign’s School of Molecular & Cellular Biology have distinguished new patterns of cell interactions with a molecular chaperone.  

Members of MCB labs earn newly-established fellowships focused on cancer research

The Beckman Institute has announced its 2023 class of six postdoctoral fellows. Fellows are selected in accordance with the core values of the institute: excellence, collaboration, integrity, transdisciplinarity, exploration, and diversity.

Possible genetic basis and mouse model found for severe nonalcoholic fatty liver disease

The SRSF1 gene acts as a guardian against DNA damage in the liver, School of MCB researchers found. When it is missing or inactivated, severe nonalcoholic fatty liver disease symptoms develop.

Experts boost activity of potential therapeutic target in triple-negative breast cancer

CHAMPAIGN, Ill. — Less than 20% of diagnosed breast cancers are designated “triple-negative,” meaning that the affected tissues lack three types of receptors often found in other breast cancer types, but TNBCs are often aggressive with ...

Cancer Center at Illinois announces 2022 cancer research grant recipients

The Cancer Center at Illinois is proud to announce the selection of nine interdisciplinary cancer research projects, involving multiple MCB faculty members, designed by University of Illinois Urbana-Champaign faculty to be funded by Cancer Center at Illinois (CCIL) developmental grant awards.

Cancer Center biochemist celebrates 40 Years at Illinois

Stephen G. Sligar has spent the last 40 years at the University of Illinois Urbana-Champaign applying his expertise in membrane proteins and his nanodisc technology to better understand biological pathways and address diseases including cancer.

MCB Faculty Help Lead the Cancer Center at Illinois in Collaborative, Interdisciplinary, and Translational Research

Several MCB faculty members are part of an exciting new campus unit known as The Cancer Center at Illinois. The Center is an interdisciplinary collaborative hub with more than 100 faculty members from departments ranging from kinesiology, human development and nutrition to electrical and computer...

Researchers determine Pol III “identity” as important regulatory mechanism and likely disease factor in cancer

Researchers at the University of Illinois Urbana-Champaign and Stanford University School of Medicine have identified a link between RNA polymerase III subunit composition and transcription, an advancement that has potential implications for future cancer research. Their findings were published in...